San Diego-based Resmed Inc. said it will add to its portfolio of digital solutions with a proposed $800 million cash acquisition of Atlanta-based Brightree, a venture-backed firm that offers cloud-based software to the post-acute care industries. Resmed (NYSE:RMD) makes sleep-disordered breathing and respiratory care devices.

The FDA has approved St. Jude Medical Inc.'s multipoint pacing (MPP) technology for the company's Quadra Assura MP cardiac resynchronization therapy defibrillator (CRT-D), the Quadra Allure MP CRT-pacemaker (CRT-P) and two new quadripolar Quartet LV leads.

After staying mostly on the sidelines of merger and acquisition activity last year, Stryker Corp. said it would be an active buyer and put its strong balance sheet to work this year. Representing the most recent step in that direction, the company agreed to shell out $1.28 billion for Physio-Control, a portfolio company of Bain Capital Private Equity that makes monitors and defibrillators, automated external defibrillators (AEDs) and CPR-assist devices along with offering data management and support services.

Stent grafts used for repairing thoracoabdominal aortic aneurysms (TAAA) are typically designed to mimic the patient's anatomy, but a new device being evaluated in an early feasibility study bucked that tradition and one of the lead investigators told Medical Device Daily that just may make all the difference. TAAAs start at the chest and extend through the abdomen and represent about 15 percent of thoracic aneurysms.